Merck (MRK) Revenue Growth (1y) (2010 - 2026)
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
Revenue Growth (1y) (Qtr) |
| 1 |
Novartis Ag |
107,124,802.25 Bn |
107,124,802.25 Bn |
- |
- |
| 2 |
Eli Lilly |
969.00 Bn |
963.72 Bn |
16.22 Bn |
55.54% |
| 3 |
Johnson & Johnson |
539.46 Bn |
517.41 Bn |
15.96 Bn |
9.91% |
| 4 |
AbbVie |
376.92 Bn |
367.57 Bn |
10.78 Bn |
12.43% |
| 5 |
Merck |
285.00 Bn |
279.35 Bn |
12.09 Bn |
4.87% |
| 6 |
Amgen |
177.58 Bn |
165.55 Bn |
5.87 Bn |
5.76% |
| 7 |
Gilead Sciences |
163.22 Bn |
155.50 Bn |
5.52 Bn |
4.39% |
| 8 |
Pfizer |
145.86 Bn |
133.09 Bn |
-1.21 Bn |
10.70% |
| 9 |
Bristol Myers Squibb |
111.90 Bn |
101.44 Bn |
8.07 Bn |
2.57% |
| 10 |
Gsk |
88.34 Bn |
83.66 Bn |
- |
- |
| Date | Value |
|---|
| Mar 31, 2026 |
4.87% |
| Dec 31, 2025 |
4.97% |
| Sep 30, 2025 |
3.72% |
| Jun 30, 2025 |
-1.90% |
| Mar 31, 2025 |
-1.56% |
| Dec 31, 2024 |
6.79% |
| Sep 30, 2024 |
4.35% |
| Jun 30, 2024 |
7.16% |
| Mar 31, 2024 |
8.89% |
| Dec 31, 2023 |
5.78% |
| Sep 30, 2023 |
6.70% |
| Jun 30, 2023 |
3.03% |
| Mar 31, 2023 |
-8.89% |
| Dec 31, 2022 |
2.29% |
| Sep 30, 2022 |
13.72% |
| Jun 30, 2022 |
27.99% |
| Mar 31, 2022 |
49.63% |
| Dec 31, 2021 |
23.50% |
| Sep 30, 2021 |
20.36% |
| Jun 30, 2021 |
21.91% |
| Mar 31, 2021 |
-11.86% |
| Dec 31, 2020 |
163.87% |
| Sep 30, 2020 |
-11.84% |
| Jun 30, 2020 |
-20.47% |
| Mar 31, 2020 |
11.47% |
| Dec 31, 2019 |
-62.27% |
| Sep 30, 2019 |
14.85% |
| Jun 30, 2019 |
12.37% |
| Mar 31, 2019 |
7.76% |
| Dec 31, 2018 |
5.42% |
| Sep 30, 2018 |
4.54% |
| Jun 30, 2018 |
5.39% |
| Mar 31, 2018 |
6.39% |
| Dec 31, 2017 |
3.14% |
| Sep 30, 2017 |
-2.00% |
| Jun 30, 2017 |
0.87% |
| Mar 31, 2017 |
1.31% |
| Dec 31, 2016 |
-0.98% |
| Sep 30, 2016 |
4.60% |
| Jun 30, 2016 |
0.60% |
| Mar 31, 2016 |
-1.20% |
| Dec 31, 2015 |
-2.55% |
| Sep 30, 2015 |
-4.58% |
| Jun 30, 2015 |
-10.51% |
| Mar 31, 2015 |
-8.17% |
| Dec 31, 2014 |
-7.40% |
| Sep 30, 2014 |
-4.31% |
| Jun 30, 2014 |
-0.69% |
| Mar 31, 2014 |
-3.81% |
| Dec 31, 2013 |
-3.55% |
| Sep 30, 2013 |
-3.97% |
| Jun 30, 2013 |
-10.57% |
| Mar 31, 2013 |
-9.04% |
| Dec 31, 2012 |
-4.53% |
| Sep 30, 2012 |
-4.44% |
| Jun 30, 2012 |
1.32% |
| Mar 31, 2012 |
1.30% |
| Dec 31, 2011 |
1.65% |
| Sep 30, 2011 |
8.06% |
| Jun 30, 2011 |
7.10% |
| Mar 31, 2011 |
1.38% |
| Dec 31, 2010 |
19.82% |
| Sep 30, 2010 |
83.89% |
| Jun 30, 2010 |
92.31% |
| Mar 31, 2010 |
112.10% |
